Source: Health Products Regulatory Authority (IE) Revision Year: 2003 Publisher: Smith & Nephew Pharmaceuticals Limited, P.O. Box 81, Hessle Road, Hull, HU3 2BN, England
Iodoflex.
Pharmaceutical Form |
---|
Impregnated dressing. |
1g unit-dose paste contains:
Cadexomer iodine 600 mg
equivalent to:
Iodine 9 mg Ph. Eur.
Cadexomer 591 mg
For excipients, see 6.1.
Active Ingredient | Description | |
---|---|---|
Cadexomer iodine |
In contact with wound exudate cadexomer iodine absorbs fluid, removes exudate, pus and debris from the wound surface. Iodine is physically immobilised within the matrix of the dry cadexomer iodine and is slowly released in an active form during uptake of wound fluid. This mechanism of release provides antibacterial activity both at the wound surface and within the formed gel. |
List of Excipients |
---|
Lanogen 1500 40% Consisting in equal parts of: Macrogol 300 Ph. Eur. |
Iodoflex is provided with a polyester gauze backing. Each unit is packed in a heat-sealed sachet of polyethylene or ionomer (inside), aluminium, polyethylene and paper (outside).
The following packages are available:
Smith & Nephew Pharmaceuticals Limited, P.O. Box 81, Hessle Road, Hull, HU3 2BN, England
PA 710/5/1
Date of first authorisation: 14 November 1997
Date of last renewal: 19 July 2002
Drug | Countries | |
---|---|---|
IODOFLEX | New Zealand |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.